Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06823349Phase 4Recruiting
Phase 4, randomised trial of dexmedetomidine in labor pain (3 arms). Primary endpoints: Duration of analgesia at 6 hours, Onset of analgesia at 6 hours and 1 more. Started Feb 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06823349.